Skip to main content

Vetivex Veterinary Hypertonic Saline Solution 7.2%, USP

This treatment applies to the following species:
Company: Dechra

For Animal Use Only


Veterinary Hypertonic Saline Solution 7.2%, USP is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment in single dose containers for parenteral administration. It contains no antimicrobial agents. Discard unused portion.

Table 1

Veterinary saline solution 7.2%, USP

Size (mL)


Sodium Chlorine (mg/mL)


Osmolarity (mEq/L)



(4.5 -7.0)

Sodium (mEq/L)


Chloride (mEq/L)


Clinical Pharmacology

Veterinary Hypertonic saline solutions 7.2%, USP has value as a source of water, electrolytes and calories.

Vetivex Veterinary Hypertonic Saline Solution 7.2%, USP Indications and Usage

For use in replacement therapy of sodium, chloride and water which may become depleted in many diseases.


This product contains no preservatives. Use entire contents when first opened. Discard any unused solution.

The parenteral administration of Veterinary Hypertonic saline solution 7.2%, USP can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states, or pulmonary edema. The risk of dilutional states is inversely proportional to the electrolyte concentrations of the injections. The risk of solute overload causing congested states with peripheral and pulmonary edema is directly proportional to the electrolyte concentrations of the injection.

In patients with diminished renal function, administration of Veterinary Hypertonic saline solution 7.2%, USP may result in sodium retention.

Adverse Reactions

Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia. If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.


Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation.

Caution must be exercised in the administration of Veterinary HYPERTONIC SALINE SOLUTION 7.2%, USP to patients receiving corticosteroids or corticotropin. Do not administer unless solution is clear, and seal is intact.

Dosage and Administration

Warm to body temperature and administer slowly by intravenous or subcutaneous injection. The amount and rate of administration must be judged by the veterinarian in relation to the condition being treated and the clinical response of the animal, being careful to avoid overhydration.


In an event of overhydration or solute overload, re-evaluate the patient and institute appropriate corrective measures.

See Warnings, Adverse Reactions and Precautions.

How Supplied

HYPERTONIC SALINE SOLUTION 7.2%, USP is supplied in plastic bags as follows:




1000 mL*


Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored in the moisture barrier overwrap at room temperature of (15°C - 30°C) OR (59°F - 86°F). Keep out of reach of children.

Directions For Use Of Plastic Container

To open:

Tear overwrap downside at slit and remove solution bag. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. If supplemental medication is desired, follow directions below.

Preparation for Administration

1. Suspend container from eyelet support.

2. Remove protector from outlet port at bottom of container.

3. Attach administration set. Refer to complete directions accompanying set.

To Add Medication


Additives may be incompatible.

To add medication before solution administration:

1. Prepare medication site.

2. Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.

3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during solution administration:

1. Close clamp on the administration set to stop the flow to the patient.

2. Prepare medication site.

3. Using syringe with 19 to 22-gauge needle, puncture resealable medication port and inject.

4. Remove container from IV pole and/or turn to an upright position.

5. Evacuate both ports by squeezing them while container is in the upright position.

6. Mix solution and medication thoroughly.

7. Return container to in-use position and continue administration.

Vetivex Veterinary Hypertonic Saline Solution 7.2%, USP Caution

Federal law (U.S.A.) restricts this drug to use by or on the order of a licensed veterinarian.


Dechra Veterinary Products, 7015 College Boulevard, Suite 525 Overland Park, KS 66211

Made in El Salvador.

For a copy of the Safety Data Sheet (SDS) or to report adverse reactions call Dechra Veterinary Products at (866) 933-2472.

© 2021 Dechra Ltd.

Vetivex is a trademark of Dechra Ltd; all rights reserved.


CPN: 1459127.0

Telephone:   913-327-0015
Toll-Free:   888-337-0929
Technical Support:   866-933-2472
Fax:   913-327-0016
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.


Copyright © 2024 Animalytix LLC. Updated: 2024-02-27